Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
MALIX LLC The ViraDx™ SARS-CoV-2/Flu A+B Rapid Antigen Test detects and differentiates SARS-CoV-2, influenza A, and influenza B using nasal or nasopharyngeal swabs. Provides accurate results in 15 minutes. For in vitro diagnostic use, Rx only.
Supplier: MALIX LLC VIRADXCOVFLU
ViraDx™ POC Test for SARS-CoV-2, Flu A & B
The ViraDx™ SARS-CoV-2/Flu A+B Rapid Antigen Test is a lateral flow immunoassay designed for in vitro rapid, simultaneous qualitative detection and differentiation of nucleocapsid antigens from SARS-CoV-2, influenza A, and influenza B. It uses anterior nasal or nasopharyngeal swab specimens from patients suspected of COVID-19 by their healthcare provider within the first five days of symptom onset. This test provides efficient, rapid, and accurate results within 15 minutes, aiding in improved patient management decisions at the point-of-care. It is intended for in vitro diagnostic use and is for prescription use only (Rx).
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?